Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study
ContributorsConte, Giulio
; Cattaneo, Fabio; de Asmundis, Carlo
; Berne, Paola; Vicentini, Alessandro; Namdar, Mehdi
; Scalone, Antonio; Klersy, Catherine; Caputo, Maria Luce; Demarchi, Andrea; Özkartal, Tardu; Salghetti, Francesca; Casu, Gavino; Passarelli, Ilaria; Mameli, Stefano; Shah, Dipen; Burri, Haran Kumar
; De Ferrari, Gaetano; Brugada, Pedro
; Auricchio, Angelo
Published inEuropace, vol. 24, no. 5, p. 845-854
Publication date2022-05
First online date2021-09-09
Abstract
Keywords
- Brugada syndrome
- Eligibility
- SMART Pass
- Screening
- Subcutaneous implantable cardioverter-defibrillator
- Sudden cardiac death
Affiliation entities
Citation (ISO format)
CONTE, Giulio et al. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study. In: Europace, 2022, vol. 24, n° 5, p. 845–854. doi: 10.1093/europace/euab230
Main files (1)
Article (Published version)
Identifiers
- PID : unige:161100
- DOI : 10.1093/europace/euab230
- PMID : 34499723
Journal ISSN1099-5129
